These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 37233985)
1. Improvement of Islet Engrafts via Treg Induction Using Immunomodulating Polymeric Tolerogenic Microparticles. Neshat SY; Bauer SJ; Rhodes KR; Quiroz VM; Wong VW; Lowmaster SM; Tzeng SY; Green JJ; Doloff JC ACS Biomater Sci Eng; 2023 Jun; 9(6):3522-3534. PubMed ID: 37233985 [TBL] [Abstract][Full Text] [Related]
2. Biomimetic tolerogenic artificial antigen presenting cells for regulatory T cell induction. Rhodes KR; Meyer RA; Wang J; Tzeng SY; Green JJ Acta Biomater; 2020 Aug; 112():136-148. PubMed ID: 32522714 [TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants. Li Y; Frei AW; Labrada IM; Rong Y; Liang JP; Samojlik MM; Sun C; Barash S; Keselowsky BG; Bayer AL; Stabler CL Front Immunol; 2021; 12():653088. PubMed ID: 34122410 [TBL] [Abstract][Full Text] [Related]
4. PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes. Graham JG; Zhang X; Goodman A; Pothoven K; Houlihan J; Wang S; Gower RM; Luo X; Shea LD Tissue Eng Part A; 2013 Jun; 19(11-12):1465-75. PubMed ID: 23432371 [TBL] [Abstract][Full Text] [Related]
5. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice. Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822 [TBL] [Abstract][Full Text] [Related]
6. Alloantigen gene transfer to hepatocytes promotes tolerance to pancreatic islet graft by inducing CD8 Le Guen V; Judor JP; Boeffard F; Gauttier V; Ferry N; Soulillou JP; Brouard S; Conchon S J Hepatol; 2017 Apr; 66(4):765-777. PubMed ID: 27914923 [TBL] [Abstract][Full Text] [Related]
7. Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma. Rhodes KR; Isser A; Hickey JW; Ben-Akiva E; Meyer RA; Kosmides AK; Livingston NK; Tzeng SY; Schneck JP; Green JJ ACS Appl Mater Interfaces; 2021 Feb; 13(7):7913-7923. PubMed ID: 33573372 [TBL] [Abstract][Full Text] [Related]
8. A novel prevascularized tissue-engineered chamber as a site for allogeneic and xenogeneic islet transplantation to establish a bioartificial pancreas. Liu Y; Yang M; Cui Y; Yao Y; Liao M; Yuan H; Gong G; Deng S; Zhao G PLoS One; 2020; 15(12):e0234670. PubMed ID: 33270650 [TBL] [Abstract][Full Text] [Related]
11. Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4 Giang S; Horwitz DA; Bickerton S; La Cava A Front Immunol; 2021; 12():628059. PubMed ID: 34122401 [TBL] [Abstract][Full Text] [Related]
12. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice. Manirarora JN; Wei CH J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409 [TBL] [Abstract][Full Text] [Related]
13. Old Dog New Tricks: PLGA Microparticles as an Adjuvant for Insulin Peptide Fragment-Induced Immune Tolerance against Type 1 Diabetes. Liu M; Feng D; Liang X; Li M; Yang J; Wang H; Pang L; Zhou Z; Yang Z; Kong D; Li C Mol Pharm; 2020 Sep; 17(9):3513-3525. PubMed ID: 32787283 [TBL] [Abstract][Full Text] [Related]
14. Induction of tolerance and prolongation of islet allograft survival by syngeneic hematopoietic stem cell transplantation in mice. Yang SF; Xue WJ; Lu WH; Xie LY; Yin AP; Zheng J; Sun JP; Li Y Transpl Immunol; 2015 Oct; 33(2):130-9. PubMed ID: 26311302 [TBL] [Abstract][Full Text] [Related]
15. CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets. Wu X; Chen PI; Whitener RL; MacDougall MS; Coykendall VMN; Yan H; Kim YB; Harper W; Pathak S; Iliopoulou BP; Hestor A; Saunders DC; Spears E; Sévigny J; Maahs DM; Basina M; Sharp SA; Gloyn AL; Powers AC; Kim SK; Jensen KP; Meyer EH Front Immunol; 2024; 15():1415102. PubMed ID: 39007132 [TBL] [Abstract][Full Text] [Related]
16. Alpha-Lipoic Acid Inhibits Spontaneous Diabetes and Autoimmune Recurrence in Non-Obese Diabetic Mice by Enhancing Differentiation of Regulatory T Cells and Showed Potential for Use in Cell Therapies for the Treatment of Type 1 Diabetes. Huang SH; Kuo SL; Chen SJ; Lin JR; Chen YW; Hong ZJ; Sytwu HK; Lin GJ Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163121 [TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo. Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161 [TBL] [Abstract][Full Text] [Related]